SELLAS Life Sciences Group Inc is a biopharmaceutical company. The company is engaged in the development of novel cancer immunotherapies for a broad range of cancer indications. Its pipeline products are Galinpepimut-S, Nelipepimut-S, GALE-301/-302 and NeuVax. SELLAS Life Sciences Group Inc is a biopharmaceutical company. The company is engaged in the development of novel cancer immunotherapies for a broad range of cancer indications. Its pipeline products are Galinpepimut-S, Nelipepimut-S, GALE-301/-302 and NeuVax.
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.01 | -0.793650793651 | 1.26 | 1.35 | 1.22 | 429642 | 1.30859974 | CS |
4 | -0.1 | -7.40740740741 | 1.35 | 1.39 | 1.15 | 418425 | 1.28263544 | CS |
12 | 0.07 | 5.93220338983 | 1.18 | 1.45 | 1.055 | 655634 | 1.20753527 | CS |
26 | 0.17 | 15.7407407407 | 1.08 | 1.72 | 0.81 | 1096080 | 1.27186434 | CS |
52 | -0.4 | -24.2424242424 | 1.65 | 1.9 | 0.4986 | 1029687 | 1.11726676 | CS |
156 | -8.98 | -87.7810361681 | 10.23 | 10.5899 | 0.4986 | 495610 | 1.78787581 | CS |
260 | 1.115 | 825.925925926 | 0.135 | 19.38 | 0.11 | 981424 | 4.60849369 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.